These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24292720)

  • 41. Osteocyte-specific WNT1 regulates osteoblast function during bone homeostasis.
    Joeng KS; Lee YC; Lim J; Chen Y; Jiang MM; Munivez E; Ambrose C; Lee BH
    J Clin Invest; 2017 Jun; 127(7):2678-2688. PubMed ID: 28628032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor necrosis factor α suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis.
    Yang N; Wang G; Hu C; Shi Y; Liao L; Shi S; Cai Y; Cheng S; Wang X; Liu Y; Tang L; Ding Y; Jin Y
    J Bone Miner Res; 2013 Mar; 28(3):559-73. PubMed ID: 23074166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene.
    Kalajzic I; Braut A; Guo D; Jiang X; Kronenberg MS; Mina M; Harris MA; Harris SE; Rowe DW
    Bone; 2004 Jul; 35(1):74-82. PubMed ID: 15207743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Osteogenesis imperfecta: a histometric analysis.
    Falvo KA; Bullough PG
    J Bone Joint Surg Am; 1973 Mar; 55(2):275-86. PubMed ID: 4696160
    [No Abstract]   [Full Text] [Related]  

  • 45. Bone defects: molecular and cellular therapeutic targets.
    Desiderio V; Tirino V; Papaccio G; Paino F
    Int J Biochem Cell Biol; 2014 Jun; 51():75-8. PubMed ID: 24704416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Osteoblast role in the pathogenesis of rheumatoid arthritis.
    Berardi S; Corrado A; Maruotti N; Cici D; Cantatore FP
    Mol Biol Rep; 2021 Mar; 48(3):2843-2852. PubMed ID: 33774802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involvement of 3D osteoblast migration and bone apatite during in vitro early osteocytogenesis.
    Robin M; Almeida C; Azaïs T; Haye B; Illoul C; Lesieur J; Giraud-Guille MM; Nassif N; Hélary C
    Bone; 2016 Jul; 88():146-156. PubMed ID: 27150828
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bone cell defects in osteogenesis imperfecta.
    Vignery A
    Connect Tissue Res; 1995; 31(4):275-8. PubMed ID: 15612367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipid metabolism disorders and bone dysfunction--interrelated and mutually regulated (review).
    Tian L; Yu X
    Mol Med Rep; 2015 Jul; 12(1):783-94. PubMed ID: 25760577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An ultrastructural and immunogold localization study of proteoglycans associated with the osteocytes of fetal bone in osteogenesis imperfecta.
    Sarathchandra P; Pope FM; Ali SY
    Calcif Tissue Int; 1996 Jun; 58(6):435-42. PubMed ID: 8661486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamics of the transition from osteoblast to osteocyte.
    Dallas SL; Bonewald LF
    Ann N Y Acad Sci; 2010 Mar; 1192():437-43. PubMed ID: 20392270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Electron microscopic and histochemical investigation of osteogenesis imperfecta tarda.
    Doty SB; Mathews RS
    Clin Orthop Relat Res; 1971 Oct; 80():191-201. PubMed ID: 5133325
    [No Abstract]   [Full Text] [Related]  

  • 53. Osteocytogenesis: Roles of Physicochemical Factors, Collagen Cleavage, and Exogenous Molecules.
    Chen X; Wang L; Zhao K; Wang H
    Tissue Eng Part B Rev; 2018 Jun; 24(3):215-225. PubMed ID: 29304315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone disease.
    Todoerti K; Lisignoli G; Storti P; Agnelli L; Novara F; Manferdini C; Codeluppi K; Colla S; Crugnola M; Abeltino M; Bolzoni M; Sgobba V; Facchini A; Lambertenghi-Deliliers G; Zuffardi O; Rizzoli V; Neri A; Giuliani N
    Exp Hematol; 2010 Feb; 38(2):141-53. PubMed ID: 19963035
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Osteoblastic differentiation.
    Nijweide PJ; van der Plas A; Olthof AA
    Ciba Found Symp; 1988; 136():61-77. PubMed ID: 3068017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis.
    Manolagas SC
    Endocr Rev; 2000 Apr; 21(2):115-37. PubMed ID: 10782361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Crispr-Cas9 engineered osteogenesis imperfecta type V leads to severe skeletal deformities and perinatal lethality in mice.
    Rauch F; Geng Y; Lamplugh L; Hekmatnejad B; Gaumond MH; Penney J; Yamanaka Y; Moffatt P
    Bone; 2018 Feb; 107():131-142. PubMed ID: 29174564
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Osteoblast precursors at different anatomic sites.
    Wurtz T; Berdal A
    Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):147-61. PubMed ID: 14696963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Osteogenesis imperfecta congenita. Scanning-electron-microscopic studies].
    Lindenfelser R; Hasselkus W; Haubert P; Krönert W
    Virchows Arch B Cell Pathol; 1972; 11(1):80-9. PubMed ID: 4626816
    [No Abstract]   [Full Text] [Related]  

  • 60. Research on Bone Cells in Health and Disease.
    Győri DS
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.